ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JORGE BARBOZA SOSA M.D.

Internal Medicine

43,516

$2.4M

1066
900 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

JAMES RACE

Internal Medicine

27,957

$1.55M

1066
719 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

HO PAK DO

Internal Medicine

10,521

$814K

1061
794 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$77
Average prescription price

Avg: $67

PAUL KIM MD

Internal Medicine

16,781

$849K

1048
933 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

RUBEN DE LOS SANTOS MD PA

Internal Medicine

32,391

$2.08M

1041
835 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

JEROME LEE SANG MD

Internal Medicine

32,089

$1.87M

1039
880 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

ENRIQUE RODRIGUEZ M.D.

Internal Medicine

24,135

$1.51M

1038
715 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

AHMED QADRI M.D.

Internal Medicine

14,854

$748K

1023
797 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

MARLENE SANCHEZ MD

Internal Medicine

17,635

$1.23M

1022
885 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

EDWARD BATES MD

Internal Medicine

24,255

$1.11M

1012
801 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

ALBERT DALLEY MD

Internal Medicine

29,527

$1.51M

1009
812 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

LEO EDWARDS M.D.

Internal Medicine

22,632

$1.16M

991
472 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

44%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

NORMA RIVERA-OPIO M.D.

Internal Medicine

21,044

$1.47M

988
773 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

CARLOS CIGARROA MD

Internal Medicine

11,182

$425K

987
841 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$38
Average prescription price

Avg: $67

JOSE LARES MD

Internal Medicine

18,111

$1.9M

984
743 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$105
Average prescription price

Avg: $67

BURCHAM FUQUA

Internal Medicine

25,056

$874K

979
829 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 27%

$35
Average prescription price

Avg: $67

VICTOR VLAHAKOS MD

Internal Medicine

14,944

$908K

979
665 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

FLOYD PIRTLE M.D.

Internal Medicine

23,033

$980K

976
853 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $67

AYHAM SHNEKER MD

Internal Medicine

27,337

$1.53M

972
723 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

ISAAC CHITRIT M.D.

Internal Medicine

24,946

$760K

966
807 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$30
Average prescription price

Avg: $67

JOSE BENAMU M.D. P.A.

Internal Medicine

23,110

$872K

961
744 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$38
Average prescription price

Avg: $67

SUNDEEP REDDY M.D.

Internal Medicine

14,468

$1.34M

945
761 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$93
Average prescription price

Avg: $67

EDWARD JUAREZ M.D.

Internal Medicine

6,979

$585K

943
716 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $67

NELSON KALAF MD

Internal Medicine

18,768

$1.71M

942
776 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$91
Average prescription price

Avg: $67

RODRIGO SOTILLO MD

Internal Medicine

18,903

$1.31M

938
831 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank